Key Takeaways
Treat biological engineering as a dual-use power, not merely a medical tool
The technology cuts both ways. In 1971, biochemist Paul Berg joined genetic material from two viruses, creating recombinant DNA, a method with promise for medicine and potential for harm. Concern about unintended consequences led Berg and colleagues to call for a pause, then to the 1975 Asilomar meeting, where scientists agreed on safety rules. Biological warfare, however, was largely absent from their discussion.
A treaty without inspection. The 1972 Biological Weapons Convention prohibits biological weapons but allows pathogen research described as defensive, and has no enforcement mechanism. The Soviet Union secretly continued offensive work after signing. The underlying dilemma remains: the same biological knowledge can support a vaccine or a weapon, while treaty language alone cannot prove which purpose is being served.
What's striking is that the risk does not come from a separate category of sinister science. It emerges from ordinary research whose uses depend on context, incentives, and oversight. That makes the governance problem resemble other dual-use fields, where the line between beneficial capability and harmful application is difficult to police after a technique spreads. The Asilomar episode offers a model of scientists slowing down to set safeguards, but voluntary consensus cannot substitute for verification. The challenge is to preserve legitimate research while making secrecy and self-certification insufficient.
A chimera can turn the expected cure into a second attack
A hidden second mechanism. A chimera is an organism combining genetic material from different sources. The book describes Soviet-era efforts to combine plague bacteria with a virus that attacks the nervous system. In the scenario, the pathogen first causes plague, while a genetic modification produces temporary euphoria that encourages infected people to socialize. Antibiotics, normally a vital treatment, then activate the second disease mechanism, leading to severe neurological damage.
The target is trust. This is presented as a hypothetical extension of reported Soviet research, not as a demonstrated weapon currently circulating. Its strategic logic is chilling: people who follow medical advice could be harmed, undermining confidence in doctors, public health agencies, and government. The weapon’s intended effect is therefore both physical injury and a crisis of belief in the institutions meant to help.
The scenario makes an important distinction between attacking people and attacking the rules they rely on. Medicine works partly because patients trust that diagnosis and treatment are based on shared evidence. A weapon that appears to falsify that bargain could produce harms beyond its direct casualties, since fear would spread through families, hospitals, and public debate. The caveat matters: the book’s dramatic antibiotic-triggered mechanism is a scenario built from historical disclosures, not proof of an existing operational agent. The broader lesson is about designing for malicious misuse, not assuming the most extreme mechanism is already real.
A lab leak can outrun response before officials know what escaped
The clock starts invisibly. In the scenario, an explosion at Russia’s Vector Institute breaches a high-containment laboratory. Satellites spot the blast, and intelligence agencies combine images, intercepted communications, environmental traces, and human sources. Yet none can immediately identify a pathogen in the air. By the time officials assemble a credible picture, an infected scientist has unknowingly exposed others, including a student who travels to Los Angeles.
Travel compresses time. The student’s infectious journey seeds further cases through crowded places, flights, and international travel. The scenario assigns the engineered plague a reproduction number, or R₀, of about 11, and assumes crowded superspreader settings could raise transmission further. These are scenario inputs, not settled measurements of a real pathogen. The point is that contagion can cross borders before testing, attribution, or diplomacy catches up.
The narrative turns a familiar epidemiological abstraction into a problem of institutional timing. A pathogen replicates without waiting for an agency to agree on jurisdiction, evidence, or public language. The account also shows why detection is not the same as identification: sensors can flag an abnormal event without knowing what biological threat it contains. That distinction is useful beyond pandemics, because early-warning systems often provide probability rather than certainty. The modeled transmission rates should be read as stress-test assumptions, not forecasts. Their value is in revealing how quickly delay can become consequential.
Build surveillance around overlooked people, not only well-connected institutions
The blind spot is social. The scenario’s first Los Angeles cases spread through Skid Row, where crowded living conditions and limited healthcare access make disease difficult to detect. The city initially treats the deaths as a drug-overdose crisis. The federal BioSense surveillance system, designed to flag unusual health patterns, lacks consistent data from homeless shelters and clinics, leaving a large, vulnerable population outside its near-real-time view.
Misclassification multiplies exposure. A sick patient reaches an urgent care clinic, then a busy public hospital that is not equipped for a high-consequence airborne pathogen. Staff, patients, and visitors are exposed before anyone recognizes the danger. The book notes that the United States has only about 100 high-level isolation beds for special pathogens. Surveillance failures are not merely technical gaps; they can reflect which communities institutions routinely count.
This section’s strongest insight is that a surveillance system inherits the priorities of the society that builds it. Data gaps cluster around people already least served by healthcare, so an outbreak may become visible only after it reaches better-connected institutions. That pattern resembles measurement problems in economics and public administration: what is not counted can disappear from policy, even when it is central to outcomes. Including shelters and street clinics would improve detection, but data collection also requires trust, privacy protections, and practical partnerships. Monitoring cannot work well when communities experience it mainly as scrutiny.
Treat delay and uncertainty as the outbreak's most dangerous accelerants
The early window is narrow. Experts in the book emphasize that action during the first 12 to 24 hours after a laboratory release could change the outcome. Yet officials initially lack the pathogen’s genetic code, a physical sample, and reliable information from Russia. Testing requires collection, paperwork, transport, preparation, and analysis; each handoff consumes time. The World Health Organization’s early-warning system can detect suspicious reports, but formal emergency declarations depend on evidence that may arrive slowly.
Diplomacy is a control measure. The United States uses a secure communications channel to request information and offer assistance, but Russia does not respond meaningfully. Cooperation could support quarantine, contact tracing, and containment. The scenario shows how political mistrust can turn a local accident into a global exposure problem, especially when governments withhold data while infections are moving through their populations.
The tension here is not simply speed versus caution. Acting on weak evidence can trigger unnecessary restrictions, while waiting for certainty can permit preventable spread. Public institutions need decision rules that specify what warrants temporary, reversible action before a diagnosis is complete. The story also makes diplomacy tangible: communication between rivals can function like emergency infrastructure. Still, cooperation cannot be assumed, especially when disclosure could expose illegal activity. Preparedness therefore depends on building channels and protocols before a crisis, not improvising trust once the stakes are already extreme.
Communicate uncertainty honestly before rumor becomes the public's operating system
Confusion creates its own outbreak. In the scenario, Russian officials describe an unusual illness, then attribute it to contaminated marmot meat, despite inconsistencies that point toward a laboratory accident. In Los Angeles, officials initially call the deaths a mass overdose. Contradictory explanations give rumors and online influencers room to shape events. The book connects this to the Soviet cover story after the 1979 Sverdlovsk anthrax leak, when authorities blamed contaminated meat.
Scarcity sharpens fear. As people hear that antibiotics may be essential but supplies are limited, they compete for medicine and distrust official instructions. The book cites a 2025 poll in which 22 percent of Americans said they trusted the federal government to do what is right. In a crisis, a communication failure does not simply confuse people; it weakens the cooperation required for quarantine, treatment, and aid.
The account correctly treats public trust as an operational resource rather than a public-relations accessory. People are more likely to follow difficult guidance when institutions explain what is known, what remains uncertain, and why advice may change. But transparency alone cannot repair distrust if services fail or decisions appear unfair. A credible message needs visible competence and equitable treatment behind it. Digital platforms can accelerate useful warnings as well as misinformation, so the aim should not be to silence every unofficial voice. It should be to make accurate, timely information easier to verify and act upon.
Stockpiles and response teams matter only if they arrive before contagion
Capacity is finite. The book contrasts a nationwide threat with roughly 100 specialized isolation beds, many of which serve large regions. A federal package of emergency supplies is designed to move within 12 hours, while some major biological response units can take one to four days to deploy. Those timelines matter when the scenario’s disease produces a new wave of infections about every day.
Exercises expose the bottlenecks. In the 2000 TOPOFF exercise, a simulated plague outbreak overwhelmed hospitals, exhausted health officials, and ended after several thousand modeled cases. The scenario’s logistics problems include too few beds, testing delays, inadequate protective equipment, strained transport, and limited antibiotics. Owning resources is not the same as being able to distribute them safely, fairly, and quickly under pressure.
This is a classic systems problem: performance depends on the slowest link, not the most impressive component. A large stockpile is of limited use if transport, staffing, dispensing sites, or public guidance fail. The same principle appears in disaster logistics, where last-mile delivery often determines whether centralized resources reach the people who need them. The book’s numbers make the mismatch vivid, though capacity changes over time and a single scenario cannot establish an exact national shortfall. The practical test is whether plans work under realistic constraints, including staff absences, damaged infrastructure, and public fear.
Emergency powers can preserve order while corroding the legitimacy they need
Containment has a civic cost. As the scenario worsens, authorities consider quarantines, military deployments, movement restrictions, and an internet shutdown. The president invokes emergency powers and the Insurrection Act, while continuity plans move senior officials to alternate sites. The Devolution Plan is a government framework for transferring essential duties to backup leaders and facilities if normal operations become impossible.
A lawful action can still deepen distrust. Quarantine can slow contagion, but forcibly confining people who may not be infected raises serious questions about rights, proportionality, and oversight. The scenario’s escalating use of force and secrecy makes order harder to distinguish from coercion. It presents a dilemma, not an easy prescription: a state may need extraordinary authority to respond, yet its response depends on public cooperation and continued legitimacy.
The section captures a central paradox of emergency governance: coercion can create immediate compliance while reducing the willingness to cooperate later. Legality is necessary, but it does not by itself make a measure proportionate, accountable, or trusted. Restrictions are more defensible when they are evidence-based, time-limited, transparently reviewed, and paired with material support for those affected. The scenario’s rapid slide toward martial law is deliberately severe, and should not be mistaken for a prediction that emergency powers inevitably produce authoritarian rule. It is a warning to design safeguards before fear narrows political choices.
Demand enforceable safeguards before biological research outruns society's ability to control it
More capability means more responsibility. The book describes a global network of high-containment laboratories and research that can alter pathogen traits. A 2025 survey it cites counted 110 BSL-4 laboratories and 3,515 BSL-3 laboratories worldwide. Some researchers argue that studying dangerous pathogens can improve defenses; critics warn that experiments can create risks that escape containment or be misused.
The rules lag behind the tools. The Biological Weapons Convention prohibits offensive biological weapons, but lacks strong inspection and enforcement. The author’s closing argument is not to panic, but to press for oversight, accountability, and limits before new biological capabilities become difficult to reverse. The scenario’s deeper question is whether institutions can govern technologies whose consequences may cross borders and outlast the researchers, companies, and governments that first created them.
The book’s call for guardrails is strongest when framed as risk governance rather than a blanket rejection of biomedical science. Research can generate real public-health benefits, but the burden of showing that high-risk work is necessary and adequately controlled should rise with its potential consequences. Independent review, transparent criteria, and meaningful international verification would address weaknesses that voluntary assurances cannot. At the same time, safeguards must avoid driving legitimate research into less accountable settings. The central policy question is not whether progress should stop, but who gets to decide which experiments are worth exposing everyone else to.
Analysis
The book’s central achievement is to portray biological catastrophe as a chain of institutional handoffs, not merely a microscopic threat. The scenario begins with a laboratory breach, then follows intelligence analysts, diplomats, health agencies, hospitals, emergency crews, military planners, and elected leaders. At each stage, the problem changes shape: uncertainty becomes delay, delay becomes exposure, and exposure becomes a crisis of coordination and legitimacy. The narrative makes abstract vulnerabilities memorable by locating them in specific places, especially Vector and Los Angeles’s Skid Row.
Its argument is also more complicated than a warning about dangerous science. Recombinant biology can support cures and countermeasures, while the same capabilities can be misused or escape containment. The book links that dual-use problem to weak treaty enforcement, opaque research oversight, underfunded public-health capacity, and social groups left out of routine surveillance. Its most useful implication is that preparedness cannot be measured by laboratory sophistication or stockpile size alone. It depends on whether information, care, and resources reach people quickly and fairly.
The scenario should be read as a stress test, not a forecast. Its extraordinary outcomes depend on stacked assumptions: a highly transmissible engineered plague, extreme lethality, a deceptive euphoria effect, antibiotic resistance, and an additional neurological mechanism. The book’s transmission rates and projected collapse are scenario parameters, not observed facts. Historical accounts and intelligence testimony support the plausibility of concern about clandestine weapons programs, but they do not verify every imagined feature of this pathogen. The immersive format can blur that boundary, making the distinction important.
That limitation does not erase the scenario’s value. Extreme cases can reveal brittle dependencies that ordinary planning overlooks, provided readers do not confuse vividness with probability. The book is ultimately strongest as a demand for serious oversight, robust public-health infrastructure, reliable crisis communication, and international cooperation before an emergency forces decisions under panic.
Review Summary
Reviews for Biological War: A Scenario are mixed, averaging 4.17/5. Many praise Jacobsen's thorough research, gripping scenario, and ability to make complex biosecurity topics accessible and terrifying. However, a significant and recurring criticism is the use of AI-generated images, widely seen as undermining credibility and cheapening the work. Some readers also take issue with perceived political bias, questionable scientific accuracy, overly dramatic writing, and unfair treatment of COVID-19's complexities. Comparisons to her previous Nuclear War: A Scenario are common, with many finding that book superior.
Glossary
Biological Weapons Convention
Treaty banning biological weaponsThe 1972 international treaty prohibiting the development, production, acquisition, transfer, stockpiling, and use of biological and toxin weapons. The book emphasizes a central weakness: the convention permits biological research presented as peaceful or defensive and has no robust inspection or enforcement system to verify compliance.
Recombinant DNA
DNA joined from different sourcesDNA created by combining genetic material from different organisms. Paul Berg’s 1971 experiment joining DNA from two viruses helped establish the technique that became central to genetic engineering. The book presents recombinant DNA as a dual-use technology, capable of supporting medical advances while also enabling the creation or modification of harmful organisms.
Biopreparat
Soviet biological weapons programThe Soviet Union’s covert biological weapons research and development system, disguised in part as civilian biological and medical work. The program included laboratories, production facilities, and scientific teams. Accounts from defectors and former participants described its scale and its development of agents intended for offensive military use despite Soviet treaty obligations.
Chimera weapon
Combined, deceptive biological agentA biological weapon designed to combine traits or genetic material associated with different organisms. In the book’s account of Soviet research, plague was explored as a carrier for a second pathogen, potentially one affecting the nervous system. The scenario extrapolates this concept into a weapon that first mimics a treatable infection, then causes a second, devastating disease.
Gain-of-function
Research adding pathogen capabilitiesExperimental research that deliberately changes a pathogen so it gains new traits, such as greater ability to infect, spread, or evade immunity. Supporters argue that studying these traits can inform preparedness and countermeasures. Critics worry that the research can create dangerous organisms or increase the chance of accidental release or misuse.
R₀
Average onward infectionsThe basic reproduction number estimates how many people one infected person would infect in a population with no existing immunity and no interventions. It is a modeling measure, not a fixed property of a disease in every setting. The book assigns its hypothetical engineered pathogen an R₀ of about 11 and uses higher figures for crowded superspreader settings.
Epidemic Intelligence from Open Sources
Open-source outbreak monitoringThe World Health Organization’s EIOS system scans public information, including news and social media, for signs of emerging disease outbreaks. It is intended to identify warning signals faster than systems dependent only on official case reports. EIOS can flag unusual patterns, but its alerts do not replace laboratory confirmation or compel governments to share information.
TOPOFF 2000
Plague response exerciseA large-scale, multi-agency exercise simulating a terrorist release of pneumonic plague in Denver. The exercise examined how public agencies and emergency services would respond as infections grew. Its after-action findings highlighted overwhelmed hospitals, limited supplies, responder fatigue, and confusion over which agencies were responsible for different parts of the response.
Dark Winter
Smallpox attack tabletop exerciseA 2001 U.S. government exercise simulating a terrorist smallpox attack in several American cities. As cases and deaths mounted, participants confronted vaccine shortages, public panic, quarantine disputes, and tensions between civil liberties and security. The exercise is used in the book to illustrate how quickly a biological crisis can become a political and social emergency.
Devolution Plan
Transfer of essential government functionsA continuity-of-government framework for transferring essential responsibilities from primary federal leaders and facilities to designated backups during a catastrophic emergency. The plan aims to keep core government functions operating if normal offices or leadership are incapacitated. In the scenario, its activation signals an extreme crisis and relocates officials to alternate facilities.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.